SG Americas Securities
CAPR icon

SG Americas Securities’s Capricor Therapeutics CAPR Stock Holding History

SG Americas Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
10,604
+4,271
+67% +$129K ﹤0.01% 2677
2026
Q1 		$193K Buy
+6,333
New +$169K ﹤0.01% 2656
2025
Q2 		– Sell
-10,045
Closed -$95K – 2993
2025
Q1 		$95K Sell
10,045
-5,272
-34% -$73.2K ﹤0.01% 3066
2024
Q4 		$211K Buy
15,317
+6,552
+75% +$115K ﹤0.01% 2101
2024
Q3 		$133K Buy
+8,765
New +$43.4K ﹤0.01% 2826

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SG Americas Securities's CAPR Position: Q2 2026 in Review

SG Americas Securities increased its Capricor Therapeutics (CAPR) stake by 67% in Q2 2026, buying an estimated $129K and bringing the position to 10,604 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

SG Americas Securities first reported a position in CAPR in Q3 2024 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • SG Americas Securities held 10,604 shares of Capricor Therapeutics worth $255K as of Q2 2026.
  • SG Americas Securities bought 4,271 Capricor Therapeutics shares in Q2 2026, an estimated $129K.
  • Capricor Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2677 holding.
  • SG Americas Securities first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.